New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BMY;PFE;DUF;CG;HLF;CALM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 23, 2014
13:39 EDTCGGIC in talks with Carlyle over possible GBP 2B takeover of RAC, Sky News says
The Government Investment Corporation of Signapore, or GIC, is in talks with the Carlyle Group over a potential takeover of its RAC division, a roadside assistance company, SkyNews reports, citing a person close to the situation. The deal would be valued at more than GBP 2B, and the deal could occur within days, Sky News added. CVC Capital Patners has also expressed interest in buying the RAC unit from Carlyle. A takeover of RAC would end its prospects of becoming a publicly traded company. The board of RAC will meet in the coming days to decide whether the division should go through with an IPO or pursue a sale of the business, Sky News added, citing an insider. GIC would consider taking a minority stake in RAC before its IPO if it decides to go public, the insider added. Reference Link
12:11 EDTPFEOn The Fly: Midday Wrap
Stocks on Wall Street were mixed and little changed at midday, amid new rules from the Obama administration on tax inversions and manufacturing data from around the globe. ECONOMIC EVENTS: In the U.S., the FHFA's home price index rose 0.1% in July to 212.7, missing expectations for a rise of 0.5%. Markit's preliminary manufacturing Purchasing Managers' Index for September came in at 57.9, slightly below the consensus forecast for a 58.0 reading. The Richmond Fed manufacturing index for September rose to 14, beating expectations for it to have dropped two points to 10. In China, HSBC's flash manufacturing Purchasing Managers' Index rose to 50.5 from a final reading of 50.2 in August, better than expectations. In Europe, Markit's composite flash PMI for the eurozone dipped to a nine-month low of 52.3, missing expectations for it to hold steady at the 52.5 seen in August. COMPANY NEWS: Shares of several companies, including a number in the pharmaceutical industry, are lower in early trading after the Treasury Department announced new regulations yesterday night that aim to make it tougher for U.S. companies to lower their tax burdens via mergers with foreign companies, otherwise known as "inversions." Among the stocks that moved lower after the new rules were announced was Astrazeneca (AZN), which had previously been a target of Pfizer (PFE) and fell about 4% near midday. Also lower were shares of both Shire (SHPG), which fell 2%, and Abbvie (ABBV), which dropped 1.6%, as the two have previously agreed to merge in a tax inversion deal. Medtronic (MDT) and Covidien (COV), which similarly agreed to an inversion merger, were down 3.3% and 2.7%, respectively. MAJOR MOVERS: Among the notable gainers was Salix Pharmaceuticals (SLXP), which rose more than 5% after The Wall Street Journal reported that Allergan (AGN) is in advanced talks on a deal to buy the company. Shares of Allergan were also up nearly 3% near midday, as the Journal also reported that Allergan rejected a recent buyout offer from Actavis (ACT). Among the noteworthy losers was Ascena Retail (ASNA), which dropped 16% after the apparel retailer's fourth quarter results and fiscal 2015 profit outlook trailed analysts' consensus estimates. Also lower following its own earnings report was auto retailer CarMax (KMX), which fell over 9%. INDEXES: Near midday, the Dow was down 32.91, or 0.19%, to 17,139.77, the Nasdaq was up 2.90, or 0.06%, to 4,530.59, and the S&P 500 was down 2.29, or 0.11%, to 1,992.00.
12:10 EDTBMYBristol-Myers to build 650,000 square foot campus in Lawrenceville, NJ
Subscribe for More Information
11:19 EDTHLF Options with increasing implied volatility
Options with increasing implied volatility: HLF VRTX TRP CLX ETP VALE
10:54 EDTPFEStocks, analysts react to Treasury inversion crackdown
Subscribe for More Information
10:21 EDTHLFHerbalife options active on wide price movement
Subscribe for More Information
09:13 EDTHLFOn The Fly: Pre-market Movers
Subscribe for More Information
06:40 EDTPFEPiper says don't dismiss potential Pfizer bid for Actavis
Piper Jaffray says it would not be dismissive of Pfizer (PFE) as a potential acquirer of Actavis (ACT). Piper believes Pfizer's public M&A comments are supportive of Actavis' exposure to complex generics and emerging markets. The firm views Actavis shares as attractively valued, irrespective of the acquisition chatter. It reiterates an Overweight rating on the stock with a $280 price target.
06:29 EDTHLFHerbalife volatility increases on pullback
Subscribe for More Information
05:49 EDTHLFStocks with implied volatility movement; HLF CMG
Subscribe for More Information
September 22, 2014
18:18 EDTHLFOn The Fly: After Hours Movers
Subscribe for More Information
18:12 EDTHLFHerbalife reverses in after-hours trading, up 2.6%
16:17 EDTHLFIcahn has not sold any of Herbalife position, Gasparino says
Carl Icahn has not sold out of his stake in Herbalife, according to sources close to the matter, reported Fox Business' Charles Gasparino on Twitter.
15:54 EDTHLFHerbalife drop attributed to rumor of Icahn liquidating stake, Kass says
Subscribe for More Information
15:52 EDTHLFHerbalife volatility spikes on wide price movement
Subscribe for More Information
15:46 EDTHLFHerbalife drops over 13% to $38.90
Subscribe for More Information
08:54 EDTCGCarlyle aims to divest shares in oil-unloading system, WSJ says
Subscribe for More Information
07:21 EDTBMYEBD Group to hold a conference
Subscribe for More Information
September 19, 2014
16:00 EDTPFEOptions Update; September 19, 2014
Subscribe for More Information
10:07 EDTPFEHigh option volume stocks
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use